Special considerations for glaucoma management in the elderly

References

• Klein BE, Klein R, Sponsel WE, et al. Prevalence of glaucoma. The Beaver Dam Eye Study. Ophthalmology. 1992;99:1499–1504.
   PubMed Web of Science ®Google Scholar
• Jiang X, Varma R, Wu S, et al. Baseline risk factors that predict the development of open-angle glaucoma in a population: the Los Angeles latino eye study. Ophthalmology. 2012;119:2245–2253.
   PubMed Web of Science ®Google Scholar
• Leske MC, Connell AM, Wu SY, et al. Risk factors for open-angle glaucoma. The Barbados Eye Study. Arch Ophthalmol. 1995;113:918–924.
   PubMed Web of Science ®Google Scholar
• Mitchell P, Smith W, Attebo K, et al. Prevalence of open-angle glaucoma in Australia. The Blue Mountains Eye Study. Ophthalmology. 1996;103:1661–1669.
   PubMed Web of Science ®Google Scholar
• Dielemans I, Vingerling JR, Wolfs RC, et al. The prevalence of primary open-angle glaucoma in a population-based study in The Netherlands. The Rotterdam Study. Ophthalmology. 1994;101:1851–1855.
   PubMed Web of Science ®Google Scholar
• Leske MC, Wu SY, Hennis A, et al. Risk factors for incident open-angle glaucoma: the Barbados Eye Studies. Ophthalmology. 2008;115:85–93.
   PubMed Web of Science ®Google Scholar
• David R, Tessler Z, Yassur Y. Epidemiology of acute angle-closure glaucoma: incidence and seasonal variations. Ophthalmologica. 1985;191:4–7.
   PubMed Web of Science ®Google Scholar
• Seah SK, Foster PJ, Chew PT, et al. Incidence of acute primary angle-closure glaucoma in Singapore. An island-wide survey. Arch Ophthalmol. 1997;115:1436–1440.
   PubMed Web of Science ®Google Scholar
• Lai JS, Liu DT, Tham CC, et al. Epidemiology of acute primary angle-closure glaucoma in the Hong Kong Chinese population: prospective study. Hong Kong Med J. 2001;7:118–123.
   PubMedGoogle Scholar
• Agarwal R, Gupta SK, Agarwal P, et al. Current concepts in the pathophysiology of glaucoma. Indian J Ophthalmol. 2009;57:257–266.
   PubMed Web of Science ®Google Scholar
• Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA. 2014;311:1901–1911.
   PubMed Web of Science ®Google Scholar
• Vohra R, Tsai JC, Kolko M. The role of inflammation in the pathogenesis of glaucoma. Surv Ophthalmol. 2013;58:311–320.
   PubMed Web of Science ®Google Scholar
• Rieck J. The pathogenesis of glaucoma in the interplay with the immune system. Invest Ophthalmol Vis Sci. 2013;54:2393–2409.
   PubMed Web of Science ®Google Scholar
• Casson RJ. Possible role of excitotoxicity in the pathogenesis of glaucoma. Clin Experiment Ophthalmol. 2006;34:54–63.
   PubMed Web of Science ®Google Scholar
• Gaasterland D, Kupfer C, Milton R, et al. Studies of aqueous humour dynamics in man. VI. Effect of age upon parameters of intraocular pressure in normal human eyes. Exp Eye Res. 1978;26:651–656.
   PubMed Web of Science ®Google Scholar
• Becker B. The decline in aqueous secretion and outflow facility with age. Am J Ophthalmol. 1958;46:731–736.
   PubMed Web of Science ®Google Scholar
• Gabelt BT, Kaufman PL. Changes in aqueous humor dynamics with age and glaucoma. Prog Retin Eye Res. 2005;24:612–637.
   PubMed Web of Science ®Google Scholar
• Alvarado J, Murphy C, Polansky J, et al. Age-related changes in trabecular meshwork cellularity. Invest Ophthalmol Vis Sci. 1981;21:714–727.
   PubMed Web of Science ®Google Scholar
• Grierson I, Howes RC. Age-related depletion of the cell population in the human trabecular meshwork. Eye. 1987;1:204–210.
   PubMed Web of Science ®Google Scholar
• Lütjen-Drecoll E, Shimizu T, Rohrbach M, et al. Quantitative analysis of ‘plaque material’ in the inner- and outer wall of Schlemm’s canal in normal- and glaucomatous eyes. Exp Eye Res. 1986;42:443–455.
   PubMed Web of Science ®Google Scholar
• Toris CB, Yablonski ME, Wang YL, et al. Aqueous humor dynamics in the aging human eye. Am J Ophthalmol. 1999;127:407–412.
   PubMed Web of Science ®Google Scholar
• Hiller R, Sperduto RD, Krueger DE. Race, iris pigmentation, and intraocular pressure. Am J Epidemiol. 1982;115:674–683.
   PubMed Web of Science ®Google Scholar
• Klein BE, Klein R, Linton KL. Intraocular pressure in an American community. The Beaver Dam Eye Study. Invest Ophthalmol Vis Sci. 1992;33:2224–2228.
   PubMed Web of Science ®Google Scholar
• Albon J, Purslow PP, Karwatowski WS, et al. Age related compliance of the lamina cribrosa in human eyes. Br J Ophthalmol. 2000;84:318–323.
   PubMed Web of Science ®Google Scholar
• Albon J, Karwatowski WS, Avery N, et al. Changes in the collagenous matrix of the aging human lamina cribrosa. Br J Ophthalmol. 1995;79:368–375.
   PubMed Web of Science ®Google Scholar
• Albon J, Karwatowski WS, Easty DL, et al. Age related changes in the non-collagenous components of the extracellular matrix of the human lamina cribrosa. Br J Ophthalmol. 2000;84:311–317.
   PubMed Web of Science ®Google Scholar
• Ren R, Jonas JB, Tian G, et al. Cerebrospinal fluid pressure in glaucoma: a prospective study. Ophthalmology. 2010;117:259–266.
   PubMed Web of Science ®Google Scholar
• Fleischman D, Berdahl JP, Zaydlarova J, et al. Cerebrospinal fluid pressure decreases with older age. PLoS One. 2012;7:e52664.
   PubMed Web of Science ®Google Scholar
• Boehm AG, Koeller AU, Pillunat LE. The effect of age on optic nerve head blood flow. Invest Ophthalmol Vis Sci. 2005;46:1291–1295.
   PubMed Web of Science ®Google Scholar
• Yang XJ, Ge J, Zhuo YH. Role of mitochondria in the pathogenesis and treatment of glaucoma. Chin Med J (Engl). 2013;126:4358–4365.
   PubMed Web of Science ®Google Scholar
• Levkovitch-Verbin H, Vander S, Makarovsky D, et al. Increase in retinal ganglion cells’ susceptibility to elevated intraocular pressure and impairment of their endogenous neuroprotective mechanism by age. Mol Vis. 2013;19:2011–2022.
   PubMed Web of Science ®Google Scholar
• Chrysostomou V, Trounce IA, Crowston JG. Mechanisms of retinal ganglion cell injury in aging and glaucoma. Ophthalmic Res. 2010;44:173–178.
   PubMed Web of Science ®Google Scholar
• Kong GY, Van Bergen NJ, Trounce IA, et al. Mitochondrial dysfunction and glaucoma. J Glaucoma. 2009;18:93–100.
   PubMed Web of Science ®Google Scholar
• Ghiso JA, Doudevski I, Ritch R, et al. Alzheimer’s disease and glaucoma: mechanistic similarities and differences. J Glaucoma. 2013;22(Suppl 5):S36–S38.
   PubMedGoogle Scholar
• Tsilis AG, Tsilidis KK, Pelidou SH, et al. Systematic review of the association between Alzheimer’s disease and chronic glaucoma. Clin Ophthalmol. 2014;8:2095–2104.
   PubMedGoogle Scholar
• Tham YC, Li X, Wong TY, et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121:2081–2090.
   PubMed Web of Science ®Google Scholar
• Campbell DG. Pigmentary dispersion and glaucoma: a new theory. Arch Ophthalmol. 1979;97:1667–1672.
   PubMedGoogle Scholar
• Niyadurupola N, Broadway DC. Pigment dispersion syndrome and pigmentary glaucoma – a major review. Clin Experiment Ophthalmol. 2008;36:868–882.
   PubMed Web of Science ®Google Scholar
• Migliazzo CV, Shaffer RN, Nykin R, et al. Long-term analysis of pigmentary dispersion syndrome and pigmentary glaucoma. Ophthalmology. 1986;93:1528–1536.
   PubMed Web of Science ®Google Scholar
• Speakman JS. Pigmentary dispersion. Br J Ophthalmol. 1981;65:249–251.
   PubMed Web of Science ®Google Scholar
• Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:701–713.
   PubMed Web of Science ®Google Scholar
• Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120:1268–1279.
   PubMed Web of Science ®Google Scholar
• The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol. 2000;130:429–440.
   PubMed Web of Science ®Google Scholar
• Collaborative Normal-Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol. 1998;126:487–497.
   PubMed Web of Science ®Google Scholar
• Garway-Heath DF, Crabb DP, Bunce C, et al. Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial. Lancet. 2015;385:1295–1304.
   PubMed Web of Science ®Google Scholar
• Leske MC, Heijl A, Hussein M, et al. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol. 2003;121:48–56.
   PubMed Web of Science ®Google Scholar
• Broadway DC, Cate H. Pharmacotherapy and adherence issues in treating elderly patients with glaucoma. Drugs Aging. 2015;32:569–581.
   PubMed Web of Science ®Google Scholar
• Patel SS, Spencer CM. Latanoprost. A review of its pharmacological properties, clinical efficacy and tolerability in the management of primary open-angle glaucoma and ocular hypertension. Drugs Aging. 1996;9:363–378.
   PubMed Web of Science ®Google Scholar
• Winkler NS, Fautsch MP. Effects of prostaglandin analogues on aqueous humor outflow pathways. J Ocul Pharmacol Ther. 2014;30:102–109.
   PubMed Web of Science ®Google Scholar
• Scichilone N, Pedone C, Battaglia S, et al. Diagnosis and management of asthma in the elderly. Eur J Intern Med. 2014;25:336–342.
   PubMed Web of Science ®Google Scholar
• Hedner J, Everts B, Möller CS. Latanoprost and respiratory function in asthmatic patients: randomized, double-masked, placebo-controlled crossover evaluation. Arch Ophthalmol. 1999;117:1305–1309.
   PubMed Web of Science ®Google Scholar
• Miyake K, Ota I, Maekubo K, et al. Latanoprost accelerates disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema in early postoperative pseudophakias. Arch Ophthalmol. 1999;117:34–40.
   PubMed Web of Science ®Google Scholar
• Chu CJ, Johnston RL, Buscombe C, et al. Risk factors and incidence of macular edema after cataract surgery: a database study of 81984 eyes. Ophthalmology. 2016;123:316–323.
   PubMed Web of Science ®Google Scholar
• Filippopoulos T, Paula JS, Torun N, et al. Periorbital changes associated with topical bimatoprost. Ophthal Plast Reconstr Surg. 2008;24:302–307.
   PubMed Web of Science ®Google Scholar
• Jayaprakasam A, Ghazi-Nouri S. Periorbital fat atrophy - an unfamiliar side effect of prostaglandin analogues. Orbit. 2010;29:357–359.
   PubMedGoogle Scholar
• Park J, Cho HK, Moon JI. Changes to upper eyelid orbital fat from use of topical bimatoprost, travoprost, and latanoprost. Jpn J Ophthalmol. 2011;55:22–27.
   PubMed Web of Science ®Google Scholar
• Athanasiov PA, Prabhakaran VC, Selva D. Non-traumatic enophthalmos: a review. Acta Ophthalmol. 2008;86:356–364.
   PubMed Web of Science ®Google Scholar
• Wax MB, Molinoff PB. Distribution and properties of beta-adrenergic receptors in human iris-ciliary body. Invest Ophthalmol Vis Sci. 1987;28:420–430.
   PubMed Web of Science ®Google Scholar
• Lahousse L, Tiemeier H, Ikram MA, et al. Chronic obstructive pulmonary disease and cerebrovascular disease: a comprehensive review. Respir Med. 2015;109:1371–1380.
   PubMed Web of Science ®Google Scholar
• Linkewich JA, Herling IM. Bradycardia and congestive heart failure associated with ocular timolol maleate. Am J Hosp Pharm. 1981;38:699–701.
   PubMedGoogle Scholar
• Doyle WJ, Weber PA, Meeks RH. Effect of topical timolol maleate on exercise performance. Arch Ophthalmol. 1984;102:1517–1518.
   PubMed Web of Science ®Google Scholar
• Bali SJ, Parmar T, Arora V, et al. Evaluation of major depressive disorder in patients receiving chronic treatment with topical timolol. Ophthalmologica. 2011;226:157–160.
   PubMed Web of Science ®Google Scholar
• Schweitzer I, Maguire K, Tuckwell V. Antiglaucoma medication and clinical depression. Aust N J Z Psychiatry. 2001;35:569–571.
   PubMed Web of Science ®Google Scholar
• Avorn J, Everitt DE, Weiss S. Increased antidepressant use in patients prescribed beta-blockers. JAMA. 1986;255:357–360.
   PubMed Web of Science ®Google Scholar
• Mincione F, Scozzafava A, Supuran CT. The development of topically acting carbonic anhydrase inhibitors as antiglaucoma agents. Curr Pharm Des. 2008;14:649–654.
   PubMed Web of Science ®Google Scholar
• Zhao JC, Chen T. Brinzolamide induced reversible corneal decompensation. Br J Ophthalmol. 2005;89:389–390.
   PubMed Web of Science ®Google Scholar
• Konowal A, Morrison JC, Brown SV, et al. Irreversible corneal decompensation in patients treated with topical dorzolamide. Am J Ophthalmol. 1999;127:403–406.
   PubMed Web of Science ®Google Scholar
• Adamsons I. Irreversible corneal decompensation in patients treated with topical dorzolamide. Am J Ophthalmol. 1999;128:774–775.
   PubMed Web of Science ®Google Scholar
• Sanchis-Gimeno JA, Lleó-Pérez A, Alonso L, et al. Corneal endothelial cell density decreases with age in emmetropic eyes. Histol Histopathol. 2005;20:423–427.
   PubMed Web of Science ®Google Scholar
• Laule A, Cable MK, Hoffman CE, et al. Endothelial cell population changes of human cornea during life. Arch Ophthalmol. 1978;96:2031–2035.
   PubMedGoogle Scholar
• Eghrari AO, Gottsch JD. Fuchs’ corneal dystrophy. Expert Rev Ophthalmol. 2010;5:147–159.
   PubMedGoogle Scholar
• Wirtitsch MG, Findl O, Kiss B, et al. Short-term effect of dorzolamide hydrochloride on central corneal thickness in humans with cornea guttata. Arch Ophthalmol. 2003;121:621–625.
   PubMedGoogle Scholar
• Toris CB, Gleason ML, Camras CB, et al. Effects of brimonidine on aqueous humor dynamics in human eyes. Arch Ophthalmol. 1995;113:1514–1517.
   PubMed Web of Science ®Google Scholar
• Greenfield DS, Liebmann JM, Ritch R. Brimonidine: a new alpha2-adrenoreceptor agonist for glaucoma treatment. J Glaucoma. 1997;6:250–258.
   PubMed Web of Science ®Google Scholar
• Fung AT, Reid SE, Jones MP, et al. Meta-analysis of randomised controlled trials comparing latanoprost with brimonidine in the treatment of open-angle glaucoma, ocular hypertension or normal-tension glaucoma. Br J Ophthalmol. 2007;91:62–68.
   PubMed Web of Science ®Google Scholar
• Novack GD, O’Donnell MJ, Molloy DW. New glaucoma medications in the geriatric population: efficacy and safety. J Am Geriatr Soc. 2002;50:956–962.
   PubMed Web of Science ®Google Scholar
• Detry-Morel M, Dutrieux C. Treatment of glaucoma with brimonidine (Alphagan 0.2%). J Fr Ophtalmol. 2000;23:763–768.
   PubMed Web of Science ®Google Scholar
• Grierson I, Lee WR, Abraham S. Effects of pilocarpine on the morphology of the human outflow apparatus. Br J Ophthalmol. 1978;62:301–313.
   Google Scholar
• Abraham SV, Teller JJ. Influence of various miotics on cataract formation. Br J Ophthalmol. 1969;53:833–838.
   PubMed Web of Science ®Google Scholar
• D’Alena P, Ferguson W. Adverse effects after glycerol orally and mannitol parenterally. Arch Ophthalmol. 1966;75:201–203.
   PubMedGoogle Scholar
• Higginbotham EJ. Considerations in glaucoma therapy: fixed combinations versus their component medications. Clin Ophthalmol. 2010;4:1–9.
   PubMedGoogle Scholar
• Wilson WS, Duncan AJ, Jay JL. Effect of benzalkonium chloride on the stability of the precorneal tear film in rabbit and man. Br J Ophthalmol. 1975;59:667–669.
   PubMed Web of Science ®Google Scholar
• Burstein NL, Klyce SD. Electrophysiologic and morphologic effects of ophthalmic preparations on rabbit cornea epithelium. Invest Ophthalmol Vis Sci. 1977;16:899–911.
   PubMed Web of Science ®Google Scholar
• Baudouin C, Labbé A, Liang H, et al. Preservatives in eyedrops: the good, the bad and the ugly. Prog Retin Eye Res. 2010;29:312–334.
   PubMed Web of Science ®Google Scholar
• Fasanella V, Agnifili L, Mastropasqua R, et al. In vivo laser scanning confocal microscopy of human meibomian glands in aging and ocular surface diseases. Biomed Res Int. 2016;2016:7432131.
   PubMed Web of Science ®Google Scholar
• Alghamdi YA, Mercado C, McClellan AL, et al. Epidemiology of meibomian gland dysfunction in an elderly population. Cornea. 2016;35:731–735.
   PubMedGoogle Scholar
• Sharma A, Hindman HB. Aging: a predisposition to dry eyes. J Ophthalmol. 2014;2014:781683.
   PubMed Web of Science ®Google Scholar
• Tatham AJ, Sarodia U, Gatrad F, et al. Eye drop instillation technique in patients with glaucoma. Eye (Lond). 2013;27:1293–1298.
   PubMed Web of Science ®Google Scholar
• Sayner R, Carpenter DM, Robin AL, et al. How glaucoma patient characteristics, self-efficacy and patient-provider communication are associated with eye drop technique. Int J Pharm Pract. 2015. doi:10.1111/ijpp.12215. [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Burns E, Mulley GP. Practical problems with eye-drops among elderly ophthalmology outpatients. Age Ageing. 1992;21:168–170.
   PubMed Web of Science ®Google Scholar
• Van Santvliet L, Ludwig A. Determinants of eye drop size. Surv Ophthalmol. 2004;49:197–213.
   PubMed Web of Science ®Google Scholar
• Winfield AJ, Jessiman D, Williams A, et al. A study of the causes of non-compliance by patients prescribed eyedrops. Br J Ophthalmol. 1990;74:477–480.
   PubMed Web of Science ®Google Scholar
• Dietlein TS, Jordan JF, Lüke C, et al. Self-application of single-use eyedrop containers in an elderly population: comparisons with standard eyedrop bottle and with younger patients. Acta Ophthalmol. 2008;86:856–859.
   PubMed Web of Science ®Google Scholar
• Dave P, Villarreal JG, Friedman DS, et al. Ability of bottle cap color to facilitate accurate patient-physician communication regarding medication identity in patients with glaucoma. Ophthalmology. 2015;122:2373–2379.
   PubMed Web of Science ®Google Scholar
• Wright C, Tawfik MA, Waisbourd M, et al. Primary angle-closure glaucoma: an update. Acta Ophthalmol. 2015. doi:10.1111/aos.12784. [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Lee JW, Liu CC, Chan JCH, et al. Predictors of success in selective laser trabeculoplasty for primary open angle glaucoma in Chinese. Clin Ophthalmol. 2014;8:1787–1791.
   PubMedGoogle Scholar
• Ayala M, Chen E. Predictive factors of success in selective laser trabeculoplasty (SLT) treatment. Clin Ophthalmol. 2011;5:573–576.
   PubMedGoogle Scholar
• Bruen R, Lesk MR, Harasymowycz P. Baseline factors predictive of SLT response: a prospective study. J Ophthalmol. 2012;2012:642869.
   PubMed Web of Science ®Google Scholar
• Tzimis V, Tze L, Ganesh J, et al. Laser trabeculoplasty: an investigation into factors that might influence outcomes. Can J Ophthalmol. 2011;46:305–309.
   PubMed Web of Science ®Google Scholar
• Hodge WG, Damji KF, Rock W, et al. Baseline IOP predicts selective laser trabeculoplasty success at 1 year post-treatment: results from a randomised clinical trial. Br J Ophthalmol. 2005;89:1157–1160.
   PubMed Web of Science ®Google Scholar
• Traverso CE, Spaeth GL, Starita RJ, et al. Factors affecting the results of argon laser trabeculoplasty in open-angle glaucoma. Ophthalmic Surg. 1986;17:554–559.
   PubMedGoogle Scholar
• Shingleton BJ, Richter CU, Bellows AR, et al. Long-term efficacy of argon laser trabeculoplasty. Ophthalmology. 1987;94:1513–1518.
   PubMed Web of Science ®Google Scholar
• AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 11. Risk factors for failure of trabeculectomy and argon laser trabeculoplasty. Am J Ophthalmol. 2002;134:481–498.
   PubMed Web of Science ®Google Scholar
• Zhang SH, Dong FT, Mao J, et al. Factors related to prognosis of refractory glaucoma with diode laser transscleral cyclophotocoagulation treatment. Chin Med Sci J. 2011;26:137–140.
   PubMedGoogle Scholar
• Murphy CC, Burnett CA, Spry PG, et al. A two centre study of the dose-response relation for transscleral diode laser cyclophotocoagulation in refractory glaucoma. Br J Ophthalmol. 2003;87:1252–1257.
   PubMed Web of Science ®Google Scholar
• Ghosh S, Manvikar S, Ray-Chaudhuri N, et al. Efficacy of transscleral diode laser cyclophotocoagulation in patients with good visual acuity. Eur J Ophthalmol. 2014;24:375–381.
   PubMed Web of Science ®Google Scholar
• Rotchford AP, Jayasawal R, Madhusudhan S, et al. Transscleral diode laser cycloablation in patients with good vision. Br J Ophthalmol. 2010;94:1180–1183.
   PubMed Web of Science ®Google Scholar
• Aptel F, Charrel T, Lafon C, et al. Miniaturized high-intensity focused ultrasound device in patients with glaucoma: a clinical pilot study. Invest Ophthalmol Vis Sci. 2011;52:8747–8753.
   PubMed Web of Science ®Google Scholar
• Aptel F, Denis P, Rouland JF, et al. Multicenter clinical trial of high-intensity focused ultrasound treatment in glaucoma patients without previous filtering surgery. Acta Ophthalmol. 2015. doi:10.1111/aos.12913. [Epub ahead of print].
   Google Scholar
• Mastropasqua R, Agnifili L, Fasanella V, et al. Uveo-scleral outflow pathways after ultrasonic cyclocoagulation in refractory glaucoma: an anterior segment optical coherence tomography and in vivo confocal study. Br J Ophthalmol. 2016. doi:308010.301136/bjophthalmol-302015-308069. [Epub ahead of print].
   Google Scholar
• Issa SA, Pacheco J, Mahmood U, et al. A novel index for predicting intraocular pressure reduction following cataract surgery. Br J Ophthalmol. 2005;89:543–546.
   PubMed Web of Science ®Google Scholar
• Poley BJ, Lindstrom RL, Samuelson TW. Long-term effects of phacoemulsification with intraocular lens implantation in normotensive and ocular hypertensive eyes. J Cataract Refract Surg. 2008;34:735–742.
   PubMed Web of Science ®Google Scholar
• Mansberger SL, Gordon MO, Jampel H, et al. Reduction in intraocular pressure after cataract extraction: the Ocular Hypertension Treatment Study. Ophthalmology. 2012;119:1826–1831.
   PubMed Web of Science ®Google Scholar
• Poley BJ, Lindstrom RL, Samuelson TW, et al. Intraocular pressure reduction after phacoemulsification with intraocular lens implantation in glaucomatous and nonglaucomatous eyes: evaluation of a causal relationship between the natural lens and open-angle glaucoma. J Cataract Refract Surg. 2009;35:1946–1955.
   PubMed Web of Science ®Google Scholar
• Mathalone N, Hyams M, Neiman S, et al. Long-term intraocular pressure control after clear corneal phacoemulsification in glaucoma patients. J Cataract Refract Surg. 2005;31:479–483.
   PubMed Web of Science ®Google Scholar
• Lai JS, Tham CC, Chan JC. The clinical outcomes of cataract extraction by phacoemulsification in eyes with primary angle-closure glaucoma (PACG) and co-existing cataract: a prospective case series. J Glaucoma. 2006;15:47–52.
   PubMed Web of Science ®Google Scholar
• Euswas A, Warrasak S. Intraocular pressure control following phacoemulsification in patients with chronic angle closure glaucoma. J Med Assoc Thai. 2005;88(Suppl 9):S121–S125.
   PubMedGoogle Scholar
• Hayashi K, Hayashi H, Nakao F, et al. Changes in anterior chamber angle width and depth after intraocular lens implantation in eyes with glaucoma. Ophthalmology. 2000;107:698–703.
   PubMed Web of Science ®Google Scholar
• Duman F, Waisbourd M, Faria B, et al. Trabeculectomy in patients with glaucoma over 80 years of age: relatively short-term outcomes. J Glaucoma. 2016;25:e123–127.
   PubMed Web of Science ®Google Scholar
• Nguyen DQ, Niyadurupola N, Tapp RJ, et al. Effect of phacoemulsification on trabeculectomy function. Clin Experiment Ophthalmol. 2014;42:433–439.
   PubMed Web of Science ®Google Scholar
• Eldaly MA, Bunce C, Elsheikha OZ, et al. Non-penetrating filtration surgery versus trabeculectomy for open-angle glaucoma. Cochrane Database Syst Rev. 2014;2:CD007059. doi:10.001002/14651858.CD14007059.pub14651852.
   PubMed Web of Science ®Google Scholar
• Arnavielle S, Lafontaine PO, Bidot S, et al. Corneal endothelial cell changes after trabeculectomy and deep sclerectomy. J Glaucoma. 2007;16:324–328.
   PubMed Web of Science ®Google Scholar
• Gedde SJ, Herndon LW, Brandt JD, et al. Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up. Am J Ophthalmol. 2012;153:804–814.
   PubMed Web of Science ®Google Scholar
• Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262–267.
   PubMed Web of Science ®Google Scholar